TABLE OF CONTENTS
|  | | | Volume 107, Issue 10 (1665-1796)
Published online 6 November 2012
|  | In this issue
 Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Letters to the Editor
Book Review
Also new today
 Advance online publication
| | | | | | Advertisement | | | | | | | Clinical Studies | Top | | Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases B Beuselinck, P Wolter, A Karadimou, R Elaidi, H Dumez, A Rogiers, T Van Cann, L Willems, J-J Body, J Berkers, H Van Poppel, E Lerut, P Debruyne, R Paridaens and P Schöffski Br J Cancer 2012 107: 1665-1671; 10.1038/bjc.2012.385 Abstract | Full Text | | | | Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems Y-Y Shao, L-C Lu, Z-Z Lin, C Hsu, Y-C Shen, C-H Hsu and A-L Cheng Br J Cancer 2012 107: 1672-1677; advance online publication, October 11, 2012; 10.1038/bjc.2012.466 Abstract | Full Text | | | | Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer R-D Hofheinz, V Heinemann, L F von Weikersthal, R P Laubender, D Gencer, I Burkholder, A Hochhaus and S Stintzing Br J Cancer 2012 107: 1678-1683; advance online publication, October 2, 2012; 10.1038/bjc.2012.434 Abstract | Full Text | | | | Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer M P Myklebust, Z Li, T H Tran, H Rui, E S Knudsen, H Elsaleh, Ø Fluge, B Vonen, H E Myrvold, S Leh, K M Tveit, R G Pestell and O Dahl Br J Cancer 2012 107: 1684-1691; advance online publication, October 25, 2012; 10.1038/bjc.2012.463 Abstract | Full Text | | Translational Therapeutics | Top | | Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells Y Lin, F M Richards, B-F Krippendorff, J L Bramhall, J A Harrington, T E Bapiro, A Robertson, D Zheleva and D I Jodrell Br J Cancer 2012 107: 1692-1701; advance online publication, October 4, 2012; 10.1038/bjc.2012.450 Abstract | Full Text | | | | Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro C Pfister, H Pfrommer, M S Tatagiba and F Roser Br J Cancer 2012 107: 1702-1713; advance online publication, October 9, 2012; 10.1038/bjc.2012.459 Abstract | Full Text | | Molecular Diagnostics | Top | | Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance G Browne, H Nesbitt, L Ming, G S Stein, J B Lian, S R McKeown and J Worthington Br J Cancer 2012 107: 1714-1721; advance online publication, October 16, 2012; 10.1038/bjc.2012.455 Abstract | Full Text | | | | Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway H Joshi, G Bhanot, A-L Børresen-Dale and V Kristensen Br J Cancer 2012 107: 1722-1728; advance online publication, October 18, 2012; 10.1038/bjc.2012.461 Abstract | Full Text | | | | Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma T Kantola, K Klintrup, J P Väyrynen, J Vornanen, R Bloigu, T Karhu, K-H Herzig, J Näpänkangas, J Mäkelä, T J Karttunen, A Tuomisto and M J Mäkinen Br J Cancer 2012 107: 1729-1736; advance online publication, October 11, 2012; 10.1038/bjc.2012.456 Abstract | Full Text | | | | Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells T Tawadros, M D Brown, C A Hart and N W Clarke Br J Cancer 2012 107: 1737-1744; advance online publication, October 4, 2012; 10.1038/bjc.2012.457 Abstract | Full Text | | | | Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma M Kobayashi, Y Miki, M Ebina, K Abe, K Mori, S Narumi, T Suzuki, I Sato, M Maemondo, C Endo, A Inoue, H Kumamoto, T Kondo, H Yamada-Okabe, T Nukiwa and H Sasano Br J Cancer 2012 107: 1745-1753; advance online publication, October 25, 2012; 10.1038/bjc.2012.422 Abstract | Full Text | | | | MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours K-P Dieckmann, M Spiekermann, T Balks, I Flor, T Löning, J Bullerdiek and G Belge Br J Cancer 2012 107: 1754-1760; advance online publication, October 11, 2012; 10.1038/bjc.2012.469 Abstract | Full Text | | Genetics & Genomics | Top | | Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer K Kämpjärvi, N Mäkinen, O Kilpivaara, J Arola, H-R Heinonen, J Böhm, O Abdel-Wahab, H J Lehtonen, L M Pelttari, M Mehine, H Schrewe, H Nevanlinna, R L Levine, P Hokland, T Böhling, J-P Mecklin, R Bützow, L A Aaltonen and P Vahteristo Br J Cancer 2012 107: 1761-1765; advance online publication, September 20, 2012; 10.1038/bjc.2012.428 Abstract | Full Text | | | | The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma M Dibb, N Han, J Choudhury, S Hayes, H Valentine, C West, Y S Ang and A D Sharrocks Br J Cancer 2012 107: 1766-1775; advance online publication, October 4, 2012; 10.1038/bjc.2012.424 Abstract | Full Text | | | | Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer V Abkevich, K M Timms, B T Hennessy, J Potter, M S Carey, L A Meyer, K Smith-McCune, R Broaddus, K H Lu, J Chen, T V Tran, D Williams, D Iliev, S Jammulapati, L M FitzGerald, T Krivak, J A DeLoia, A Gutin, G B Mills and J S Lanchbury Br J Cancer 2012 107: 1776-1782; advance online publication, October 9, 2012; 10.1038/bjc.2012.451 Abstract | Full Text | | | | Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer T Pal, M R Akbari, P Sun, J-H Lee, J Fulp, Z Thompson, D Coppola, S Nicosia, T A Sellers, J McLaughlin, H A Risch, B Rosen, P Shaw, J Schildkraut and S A Narod Br J Cancer 2012 107: 1783-1790; advance online publication, October 9, 2012; 10.1038/bjc.2012.452 Abstract | Full Text | | Letters to the Editor | Top | | Comment on ‘A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens’ N Normanno, A Rachiglio, C Roma, F Ciardiello and C Pinto Br J Cancer 2012 107: 1791-1792; advance online publication, September 25, 2012; 10.1038/bjc.2012.431 Full Text | | | | Reply to comment by Normanno et al on ‘A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens’ D G de Castro and F Lopez-Rios Br J Cancer 2012 107: 1793-1794; advance online publication, September 25, 2012; 10.1038/bjc.2012.432 Full Text | | Book Review | Top | | Natural Killer T cells – balancing the regulation of tumor immunity M W Lowdell Br J Cancer 2012 107: 1795-1796; 10.1038/bjc.2012.453 Full Text | | | | | | | Advertisement | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment
Keep a civil tongue.